В допълнение на това, има данни за редки случаи на чернодробно/ бъбречно увреждане или фатален хепатит.
Patients with chronic hepatitis B or C and treated with antiretroviral agents are at increased risk for severe and potentially fatal liver adverse events and may require blood tests for control of liver function.